- Home
- NAMS vs CSAN Comparison
NAMS vs CSAN Comparison
Compare NAMS & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | CSAN |
|---|---|---|
| Founded | 2019 | 1936 |
| Country | Netherlands | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | CSAN |
|---|---|---|
| Price | $32.21 | $3.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $46.40 | $4.75 |
| AVG Volume (30 Days) | 764.0K | ★ 2.7M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,243,000.00 | ★ $7,988,294,917.00 |
| Revenue This Year | N/A | $270.61 |
| Revenue Next Year | $10.46 | $0.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.91 | 2.13 |
| 52 Week Low | $14.06 | $3.72 |
| 52 Week High | $42.00 | $6.25 |
Technical Indicators
Market Signals| Indicator | NAMS | CSAN |
|---|---|---|
| Relative Strength Index (RSI) | 39.50 | 37.06 |
| Support Level | $30.97 | $3.72 |
| Resistance Level | $32.45 | $4.04 |
| Average True Range (ATR) | 1.64 | 0.12 |
| MACD | -0.24 | 0.02 |
| Stochastic Oscillator | 29.97 | 32.84 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.